Toggle light / dark theme

Diagnosing, Treating, And Preventing Neglected Tropical Diseases — Dr. Maria Elena Bottazzi, BCM National School of Tropical Medicine, Baylor University.


Dr. Maria Elena Bottazzi (https://www.bcm.edu/people-search/maria-bottazzi-18431) is Distinguished Professor of Biology, Associate Dean of the National School of Tropical Medicine, and Professor in the Departments of Pediatrics, Molecular Virology and Microbiology, Integrative Molecular and Biomedical Sciences, and Translational Biology and Molecular Medicine, at Baylor College of Medicine.

Dr. Bottazzi is also Co-Director, Texas Children’s Hospital Center for Vaccine Development, Adjunct Professor, Department of Bioengineering, Rice University, and Editor-in-Chief, Current Tropical Medicine Reports.

Dr. Botazzi has a degree in microbiology from Universidad Nacional Autónoma de Honduras, a PhD from University Of Florida, did a Post-Doctoral Fellowship at University Of Pennsylvania and at University Of Miami Hospital And Clinics, and a Fellowship at American Association for the Advancement of Science Leshner Leadership Institute.

Dr. Botazzi is involved in a range of activities related to the development of novel vaccines and adjuvants for neglected tropical diseases (Chagas Disease, Leishmaniasis, Human Hookworm Vaccine, Schistosomiasis Vaccine), as well as extensive work on Covid vaccines.

Your DNA is in a database.


Your genetic code is probably already in a database, without you ever giving a sample or permission. This video is sponsored by Brilliant. The first 200 people to sign up via https://brilliant.org/veritasium get 20% off a yearly subscription.

▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
A huge thanks to Paul Holes, Billy Jensen, Brett Williams, Dr Connie Bormans and Dr Doc Edge for being part of this video. Thanks to Verogen and Family Tree DNA for giving me access to film.

Thanks to Sonya Pemberton, Joe Hanson, Raquel Nuno, CGP Grey, and numerous Patreon supporters for helpful feedback on an earlier version of this video.

▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
References:
Phillips, C. (2018). The Golden State Killer investigation and the nascent field of forensic genealogy. Forensic Science International: Genetics, 36 186-188. — https://ve42.co/Phillips2018

Guerrini, C. J., Robinson, J. O., Petersen, D., & McGuire, A. L. (2018). Should police have access to genetic genealogy databases? Capturing the Golden State Killer and other criminals using a controversial new forensic technique. PLoS biology, 16(10), e2006906. — https://ve42.co/Guerrini.

Ram, N., Guerrini, C. J., & McGuire, A. L. (2018). Genealogy databases and the future of criminal investigation. Science, 360(6393), 1078-1079. — https://ve42.co/Ram2019

▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀▀
Special thanks to Patreon supporters: Andrew, Diffbot, Micah Mangione, MJP, Gnare, Nick DiCandilo, Dave Kircher, Edward Larsen, Burt Humburg, Blake Byers, Dumky, Evgeny Skvortsov, Meekay, Bill Linder, Paul Peijzel, Mac Malkawi, Michael Schneider, Big Badaboom, Ludovic Robillard, Jim buckmaster, fanime96, Juan Benet, Ruslan Khroma, Robert Blum, Richard Sundvall, Lee Redden, Vincent, Marinus Kuivenhoven, Alfred Wallace, Clayton Greenwell, Michael Krugman, Cy ‘kkm’ K’Nelson, Sam Lutfi, Ron Neal.

Sickle-cell disease is incurable and affects 15,000 people in the UK.

And the National Institute for Health and Care Excellence said the hope of reducing health inequalities for black people, who are predominantly affected and often have poorer health to start with, made the drug worth recommending.

It called it “an innovative treatment”.


The hope of reducing health inequalities for black people made it worth recommending, the regulator says.

Enterprises of all sizes and across virtually all markets are scrambling to augment their analytics capabilities with artificial intelligence (AI) in the hopes of gaining a competitive advantage in a challenging post-pandemic economy.

Plenty of anecdotal evidence points to AI’s ability to improve analytics, but there seems to be less conversation around how it should be implemented in production environments, let alone how organizations should view it strategically over the long term.

What’s so special about this artificial kidney? The device was engineered to sustainably support a culture of human kidney cells without provoking an immune response.

This means that kidney failure patients can forgo the often painful and uncomfortable dialysis procedures and the lifetime on immunosuppressant drugs that are taken when a kidney transplant is performed and which can have severe side effects. project just earned a $650,000 prize from KidneyX for its first-ever demonstration of a functional prototype.

According to kidney.org, kidney disease causes more deaths than breast cancer or prostate cancer, affecting an estimated 37 million people in the U.S. or 15% of the adult population; more than 1 in 7 adults.

Scientists in Montreal discover a new enzymatic complex that can stop cells from aging, opening the way to possible new cancer therapies.

Researchers at Université de Montréal and McGill University have discovered a new multi-enzyme complex that reprograms metabolism and overcomes “cellular senescence,” when aging cells stop dividing.

In their study published on September 16 2021, in Molecular Cell, the researchers show that an enzyme complex named HTC (hydride transfer complex) can inhibit cells from aging.